Bioprogress is a stock I have been in and out of quite a few times since it floated in May but not much mention here on the Investors' Room. Does anyone else follow this stock. I see it is up 1.5p today and a few good buyers seem to have appeared.

Thanks for posts Sam24 and AdieH.
Sam24 - Hope your reliable source proves to be just that. I am new to this game and got a little burnt on these buying at 74 in early Feb. Bought again at 34 in April so hoping for a bit of a bounce back to cover my losses ( I know this can be risky !!! )
Luckily also hold SEO AdieH which has been nothing short of fantastic for me.

BPRG up 16.42 % As Peter Sellers would say. Very interesting.
I wonder if there is any takeover approach. They are having a financial review and ? based on that review it is possible.
*************************************************************
(AFX) - BioProgress PLC said it is undergoing a "thorough strategic and financial review" as a result of poor trading at one unit and expected increased overheads.
The group, which provides delivery mechanisms for the pharmaceutical oral dosage markets, said current trading levels at its BioTec Films subsidiary in Tampa are not as strong as previously anticipated and are unlikely to reach levels indicated in previous announcements.
Wednesday, 13/04/05, 08:31



(AFX) - BioProgress PLC said that Graham Hind has resigned as Chief Executive Officer.
The company has appointed Richard Trevillion, currently a Non-Executive Director, to act as interim Chief Executive Officer.
The strategic and financial review, announced on April 13, is continuing, BioProgress said.
Friday, 29/04/05, 15:10

**************************************************************

BPRG is making a comeback...good news on the way.

Some thing is brewing,like hlyeo said good news on the way,lets hope.

hlyeo98 why don't you expand on that

It looks like sell now, buy later @ cheaper price, that's
what I would do.........

Sam24, I am confused by your last comment of sell now buy later !! Yesterday you said good news was on the way from a reliable source.

Am I missing your tongue in cheek humour here ?

I am telling only the short termers.... sell now buy later
at a cheaper price!

Can't wait for Dil's response to that :)

Wonder if this was walked up by the MMs on the back of SEO success to shift stock? Following a good start to the day, on the way back down now. There certainly hasn't been anything to support the recent rise.

PTH

I wouldn't be surprised at all if it goes to 44p today, I am talking
to short termers only.

Buyers are back, I think its good time to buy/top up NOW.

For those still holding BPRG and/or bought during in following the recent drop, a spot of hope.


CEO Appointment
BioProgress plc (AIM: BPRG; NASDAQ: BPRG), the provider of innovative delivery mechanisms for the pharmaceutical oral dosage markets, announces the appointment of Richard Trevillion as Chief Executive Officer.

Mr Trevillion joined the Board as a Non-Executive Director in February 2005 and became interim Chief Executive at the end of April. He has a wide range of experience within the global healthcare and technology sectors, both as advisor and principal, and has been responsible for the development of a number of high growth technology businesses.

****************************
Commenting on his appointment, Richard Trevillion said: I am delighted to accept the invitation of the Board to become CEO of BioProgress. The Company has a strong suite of technology and intellectual property, combined with a highly motivated team of professionals dedicated to the further commercialisation and development of the business.


****************BioProgress has a strong balance sheet **********************
and international presence which we will use as a solid foundation to move the business forward to the next stages of growth and development.
*********************************
The financial and strategic review will be completed by the end of this month, and the Board will provide shareholders with a report on the principal conclusions as soon as possible.


Forward-Looking Information.

The Ordinary Shares of BioProgress plc are registered under the US Securities and Exchange Act of 1934. To the extent that this announcement contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, this paragraph applies. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may vary materially from the expectations contained in the forward-looking statements. The forward-looking statements in this release include statements addressing future financial and operating results and the timing and benefits of the reorganisation. Detailed information about factors pertinent to the business of the company that could cause actual results to differ is set forth in the Companys filings with the Securities and Exchange Commission. The Company is under no obligation to (and expressly disclaim any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise. This announcement is for information only and does not constitute an offer or invitation to acquire or dispose of any securities or investment advice. The distribution of the announcement and/or issue of securities in certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes are required to inform themselves about and to observe such restrictions.

Enquiries:

BioProgress plc


Richard Trevillion, CEO
Tel: +44 (0) 1354 655674


www.bioprogress.com


UK Media enquiries: Abchurch


Samantha Robbins
Tel: +44 (0) 20 7398 7700

samantha.robbins@abchurch-group.com
www.abchurch-group.com


US Investor enquiries: Taylor Rafferty


Andrew Saunders
Tel: +1 212 889 4350

andrew.saunders@taylor-rafferty.com
www.taylor-rafferty.com


For further information, contact us.

Where have the rampers gone like "good news" hyleo ?

Crock of sh*te ... 22p next stop.

Dil I don't think I would short this now. I think this drop back is due to change of CEO and appraisal which seems ?fair. As before it will be a slow return to the crazy heights of before. But the "products" are useful and required in the medical field.

May be wrong but I will hold what I got for a tad longer.

dragged down by fall in drugs market

The change in CEO was positive news Fred. My sentiments are the opposite , I wouldn't like to be long with the amount of uncertainty knocking about.

38p had to hole methinks. Might be looking to return to 30-32p soon?

This afternoon would be nice Al ... I would overtake Kayak in the Champions investor game then :-)

LOVELY NEWS I THINK,AND LOOK AT THE PRICE AS ITS RECOVERED SOME WHAT FROM TODAYS LOWS.